AI continues to gain momentum across the life sciences industry, promising to reshape medical writing and regulatory processes by improving speed, consistency, and efficiency. But for many organizations, realizing the full value of AI remains a challenge.
At TrialAssure, we’ve seen firsthand how a lack of clear implementation roadmaps, the wrong platform choices, or solutions misaligned with daily workflows can stall progress and waste resources for Sponsors, CROs, and vendors alike.
That’s why we’re excited to host a new interactive webinar: A Clear Path to Successful AI Adoption in Medical Writing with Structured GenAI Pilots. This session will explore how a well-designed pilot program can offer a smarter, lower-risk approach to implementing generative AI in your environment.
What You’ll Learn
In this session, our team will walk through a proven framework for launching GenAI pilots within real-world clinical and regulatory workflows. We’ll also showcase the LINK AI Pilot, highlighting how structured pilots can be used to evaluate system integration, benchmark productivity gains, and build internal alignment for broader adoption.
You’ll gain insights into:
- Building a robust business case using performance data from AI pilots
- Demonstrating measurable outcomes like reduced draft timelines and faster summary creation
- Reviewing real-world pilot data that shows improvements in turnaround time, quality, and compliance
- Driving stakeholder buy-in through transparency and actionable metrics
Register Now
Reserve your spot for the live webinar on May 29, 2025 at 11:00 AM ET: Click here to register
We look forward to having you join us for this important discussion!
